Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals
- Conditions
- UltrasoundBotulinum ToxinSpasticityAdults
- Interventions
- Drug: Botulinum toxin injection under anatomical landmarkDrug: Ultrasound-guided botulinum toxin injection
- Registration Number
- NCT06941883
- Lead Sponsor
- Tanta University
- Brief Summary
This study aimed to compare the safety and outcome of ultrasound (US)- guided botulinum toxin (BoNT) injection and anatomically guided injection in muscle spasticity of different causes in adults.
- Detailed Description
One of the major complications of neurological diseases is spasticity which is defined as an increased velocity-dependent muscle tone.
A large volume of clinical data has demonstrated the efficacy and safety of botulinum toxin type A (BoNT-A) products for treating conditions such as spasticity.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 68
- Age > 18 years old.
- Both sexes.
- Patients with muscle spasticity.
- Patients with contraindications to botulinum toxin injection as allergy, myasthenia gravis, and cerebral palsy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Botulinum toxin injection under anatomical landmark Botulinum toxin injection under anatomical landmark Patients received botulinum toxin injections under the anatomical landmark. Ultrasound-guided botulinum toxin injection Ultrasound-guided botulinum toxin injection Patients received ultrasound-guided botulinum toxin injection
- Primary Outcome Measures
Name Time Method Assessment the range of movement 6 months after the procedure The range of movement regarding forearm pronation, thumb flexion, ankle inversion and fingers flexion according to modified Ashworth scale (MAS): score zero indicate no increase in tone, score 1 indicate slight increase in tone, catch or release at end range of motion (ROM), score 1 + indicate a slight increase in tone catch, release, resistance through rest ROM (1/2 ROM), score 2 indicate more marked increase in tone through ROM but affected part moved easily, score 3 indicate a considerable increase in tone, passive movement difficult, score 4 indicate affected part in rigid flexion and extension. It was assessed after three and six months.
- Secondary Outcome Measures
Name Time Method Assessment the quality of life 6 months after the procedure Patients' quality of life (QOL) was assessed before and after intervention with the World Health Organization (WHO)-QOL scale). The WHOQOL is a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then transformed linearly to a 0-100 scale.
Trial Locations
- Locations (1)
Tanta University
🇪🇬Tanta, El-Gharbia, Egypt